Skip to content
Screener

CapEx at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$1.32B+26.7%
Stryker logo
StrykerSYK
$202M+10.4%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
$12.65M+77.9%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
$54.2M+8.2%
Treace Medical Concepts, Inc. logo
Treace Medical Concepts, Inc.TMCI
$2.2M-53.8%
ESAB logo
ESABESAB
$17.75M+93.3%

Segments

By segment

See full
Prevention & Recovery$6.5M
Reconstructive$1.5M-95.6%

Other financials

Income statement

See full
Revenue$582.8M+3.2%
Gross profit$359.2M+7.3%
Operating income$17.4M+204%
Net income-$1.2M+96.8%
EPS (diluted)-$0.02+96.9%

Balance sheet

See full
Cash & equivalents$12.6M-71.5%
Total debt$1.3B-6.4%
Total equity$1.5B-42.7%
Total assets$3.8B-25.0%

Cash flow

See full
Operating cash flow$75.0M+57.1%
Free cash flow$31.1M

Valuation

See full
Market cap$1.52B+3.1%
Enterprise value$2.81B-0.4%
P/S0.7×0.0×

Profitability

See full
Gross margin61.1%+3.5pp
Operating margin-45.1%+19.4pp
Net margin-48%+17.7pp
FCF margin-3.1%-1.1pp

Returns & leverage

See full
Return on equity-54.3%+672pp
Debt / equity0.9×+0.3×
Current ratio-0.3×

Where this comes from

Reported directly by Enovis in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The source filing: Enovis’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 6:45 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001420800-26-000035
Line itemSix Months Ended / July 3, 2026Six Months Ended / July 4, 2025
Other operating assets and liabilities4,32132,145
Net cash provided by operating activities98,98346,173
Cash flows from investing activities:
Purchases of property, plant and equipment and intangibles(96,699)(87,631)
Payments for acquisitions, net of cash received, and investments(1,407)(24,290)
Cash received upon settlement of derivatives1,601
Net cash used in investing activities(98,106)(110,320)
Cash flows from financing activities:

Item 1. Financial Statements

FAQ

What is Enovis's capex?
Enovis (ENOV) reported capex of $43.9M in Q2 2026.
How has Enovis's capex changed year-over-year?
Enovis's capex decreased by 1.1% year-over-year, from $44.37M to $43.9M.
What is the long-term trend for Enovis's capex?
Over 4 years (2021 to 2025), Enovis's capex has grown at a 17.3% compound annual growth rate (CAGR), from $104.24M to $197.38M.
What does capex mean?
Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.

Ask your AI about Enovis's capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude